CATX insiders were on both sides of the trade this year. Buys came to roughly $42,000 (two buyers), sales to $1.6 million (four sellers).
Hunt Jonathan Robert (Executive Officer) made the biggest buy, worth around $22,000.
Big money check: 130 institutions held CATX as of Q2 2026, and more funds bought than sold. Quarter by quarter: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | 167,149 | $3.15 | $527K | SEC |
| Sep 8, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | 80,783 | $3.11 | $251K | SEC |
| Sep 4, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | 42,129 | $3.11 | $131K | SEC |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | 78,145 | $3.14 | $245K | SEC |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | 35,769 | $3.12 | $112K | SEC |
| Sep 3, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | 35,769 | $3.12 | $112K | SEC |
| Sep 2, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | 78,145 | $3.14 | $245K | SEC |
| Nov 17, 2025 | Hunt Jonathan Robert | Executive Officer | Buy | 11,000 | $2.03 | $22K | SEC |
| Nov 14, 2025 | Williamson Robert F III | Director | Buy | 9,498 | $2.10 | $20K | SEC |
| Apr 1, 2025 | Williamson Robert F III | Director | Buy | 38,145 | $2.14 | $82K | SEC |
| Apr 1, 2025 | Williamson Robert F III | Director | Buy | 22,192 | $2.27 | $50K | SEC |
| Apr 1, 2025 | Graham Juan | CFO | Buy | 33,333 | $2.25 | $75K | SEC |
| Apr 1, 2025 | Woods Lori A | Director | Buy | 23,475 | $2.13 | $50K | SEC |
| Apr 1, 2025 | Spoor Johan M. | CEO | Buy | 4,650 | $2.21 | $10K | SEC |
| Apr 1, 2025 | Spoor Johan M. | CEO | Buy | 22,026 | $2.24 | $49K | SEC |
In the last 12 months Perspective Therapeutics, Inc. insiders made open-market purchases worth about $42,000 and sales worth about $1.6 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CATX was filed on 2026-09-08.
130 investment managers reported holding CATX in SEC Form 13F filings for Q2 2026.
No congressional trades in CATX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).